Xylocaine Injection, Solution
Product Images NDC 70518-4152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 70518-4152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Xylocaine with EPINEPHrine, a medication containing Lidocaine HCI and EPINEPHrine 1%. It comes in a 20mL vial with a concentration of 10mg/mL of Lidocaine and 0.01mg/mL of EPINEPHrine. The medication is for injection use only and should be kept out of reach of children. Manufactured by Fresenius Kabi, it is sterile and should be protected from light. It is important to check the color and clarity of the medication before use and follow the directions for use provided in the package insert. It is not intended for Caudal or Epidural use. Storage should be between 20-25°C (58-77°F) with excursions permitted up to 15-30°C (59-86°F) as per USP standards. Not for repackaging.*
FDA Label Image

Mm2 (Xylocaine Epinephrine 200mg 20ml(10mg mL) 0.01mg mL 70518 4152 00)

Mm2 (Xylocaine   Epinephrine 200mg 20ml(10mg mL) 0.01mg mL 70518 4152 00)
This is a description of Xylocaine with Epinephrine, an injection containing Lidocaine HCI and Epinephrine used for far infiltration and nerve block. The medication is in a multiple-dose vial, sterile, and non-pyrogenic. It is important to protect it from light and avoid autoclaving due to the presence of Epinephrine. The medication is not suitable for caudal or epidural use and should not be administered if it appears pinkish or darker than slightly yellow, or if it contains a precipitate. The package insert provides detailed directions for use, and it is recommended to store the medication at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The manufacturer is Fresenius Kabi in Lake Zurich, IL, and the repackaging was done by Remedy Repack Inc.*
FDA Label Image

Structure 1 (Xyl01 0002 01)

FDA Label Image

Structure 2 (Xyl01 0002 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.